Arcutis Biotherapeutics, Inc. short interest in 2022
In 2022, Arcutis Biotherapeutics, Inc.'s disclosed short interest ran from 4.59% of shares outstanding on 14 Jan 2022 to 17.49% on 30 Dec 2022, a change of +12.90 percentage points. The year's high was 17.49% on 30 Dec 2022 and its low 4.59% on 14 Jan 2022, averaging 9.30% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.44 days on 28 Feb 2022. Full history: Arcutis Biotherapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 4.59% (14 Jan 2022)
- End of year
- 17.49% (30 Dec 2022)
- Change
- +12.90 pp
- High
- 17.49% (30 Dec 2022)
- Low
- 4.59% (14 Jan 2022)
- Average
- 9.30%
- Highest days to cover
- 17.44 (28 Feb 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 4.59% | 11.96 | |
| 31 Jan 2022 | 5.78% | 14.04 | |
| 15 Feb 2022 | 6.18% | 15.05 | |
| 28 Feb 2022 | 6.39% | 17.44 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 7.40% | 12.13 | |
| 31 Mar 2022 | 6.72% | 10.88 | |
| 14 Apr 2022 | 5.68% | 6.98 | |
| 29 Apr 2022 | 5.74% | 12.45 | |
| 13 May 2022 | 5.66% | 10.90 | 10-Q filed, results (8-K) |
| 31 May 2022 | 6.00% | 6.16 | |
| 15 Jun 2022 | 6.41% | 9.49 | |
| 30 Jun 2022 | 6.78% | 5.53 | |
| 15 Jul 2022 | 7.63% | 9.28 | |
| 29 Jul 2022 | 8.88% | 9.81 | |
| 15 Aug 2022 | 10.10% | 4.91 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 9.92% | 11.26 | |
| 15 Sep 2022 | 10.08% | 7.34 | |
| 30 Sep 2022 | 11.62% | 6.63 | |
| 14 Oct 2022 | 13.29% | 9.53 | |
| 31 Oct 2022 | 15.59% | 12.27 | |
| 15 Nov 2022 | 13.22% | 9.14 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 15.58% | 14.73 | |
| 15 Dec 2022 | 16.36% | 13.42 | |
| 30 Dec 2022 | 17.49% | 10.68 |
See also: Arcutis Biotherapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.